1. A Phase 2 Trial of Nab-paclitaxel in Combination With Anti-PD1 Therapy in Advanced Urothelial Cancer. Issue 1 (1st January 2023) Authors: Tsung, Irene; Green, Edward; Palmbos, Phillip; Sloan, Zachery; Reichert, Zachery R.; Vaishampayan, Ulka; Smith, David C.; Caram, Megan E. V.; Yentz, Sarah; Daignault-Newton, Stephanie; Hurley, Laura; Nguyen, Charles B.; Kraft, Shawna; Alva, Ajjai Journal: Journal of urology Issue: Volume 209:Issue 1(2023) Page Start: 121 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. TROPHY-U-01: A Phase II Open-Label Study of Sacituzumab Govitecan in Patients With Metastatic Urothelial Carcinoma Progressing After Platinum-Based Chemotherapy and Checkpoint Inhibitors. Issue 22 (1st August 2021) Authors: Tagawa, Scott T.; Balar, Arjun V.; Petrylak, Daniel P.; Kalebasty, Arash Rezazadeh; Loriot, Yohann; Fléchon, Aude; Jain, Rohit K.; Agarwal, Neeraj; Bupathi, Manojkumar; Barthelemy, Philippe; Beuzeboc, Philippe; Palmbos, Phillip; Kyriakopoulos, Christos E.; Pouessel, Damien; Sternberg, Cora N.; Ho... Journal: Journal of clinical oncology Issue: Volume 39:Issue 22(2021) Page Start: 2474 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗